Raltitrexed
- Generic Name
- Raltitrexed
- Brand Names
- Tomudex
- Drug Type
- Small Molecule
- Chemical Formula
- C21H22N4O6S
- CAS Number
- 112887-68-0
- Unique Ingredient Identifier
- FCB9EGG971
- Background
Raltitrexed (brand name Tomudex®) is a chemotherapy drug manufactured AstraZeneca Company, is an antimetabolite used in chemotherapy. It is an inhibitor of thymidylate synthase.
- Indication
For the treatment of malignant neoplasm of colon and rectum
- Associated Conditions
- Advanced Colorectal Cancer, Pleural Mesotheliomas
- Associated Therapies
- -
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
Phase 3
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-07-18
- Target Recruit Count
- 256
- Registration Number
- NCT00004920
- Locations
- 🇬🇧
Western General Hospital, Edinburgh, Scotland, United Kingdom
🇧🇪U.Z. Gasthuisberg, Leuven, Belgium
🇵🇱Regional Lung Diseases Hospital, Poznan, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath